Cameron Gardner

Cameron Gardner is a senior leader in research and development within the biotechnology sector, currently serving as Senior Vice President of R&D at JURA Bio, Inc. His expertise spans I/O, Cell and Gene Therapy, and Biologics Discovery, with a strategic focus on developing novel therapeutics for autoimmune diseases and T cell leukemias and lymphomas. He has progressed through various leadership roles at JURA Bio, demonstrating a strong trajectory in guiding scientific innovation. google+2

With a robust academic background, Cameron possesses a PhD in Clinical Medicine (Immunology) from the University of Oxford and specialized training in synthetic biology from Harvard Medical School. This foundational knowledge in immunology and synthetic biology underpins his work in gene and cell therapy development, enabling him to contribute significantly to cutting-edge biological research and its therapeutic applications. orcid+3

Cameron's research contributions include significant work in gene editing, particularly for severe combined immunodeficiency, and the development of artificial thymic organoid systems for T-cell differentiation studies. His publications reflect involvement in manufacturing-aware generative model architectures for biological sequence design, showcasing his engagement with advanced computational and biological engineering techniques. orcid+2